This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Indian Pharmaceutical Alliance (IPA) questions the reliance on the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) in the Ohio State University report titled, Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.
With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Unveiling excellence in pharma Day 1 of the event showcased the Pharma Connect Congress, which addressed pivotal themes shaping the pharmaceutical landscape.
CPHI Europe, reportedly, the world’s largest pharmaceutical event, will return to Messe Frankfurt from October 28-30, 2025. The event will gather the entire supply chain, including ingredients, finished dosages, machinery, bio, and packaging. CPHI events highlight industry trends, with analysts predicting growth in 2025.
As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.
CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. This year’s event marks the 20th anniversary of the CPHI Pharma Awards.
FINEARTS-HF is a randomised, double-blind, placebo-controlled, multicenter, event-driven Phase III trial to assess the efficacy and safety of finerenone on top of standard therapies in patients with a mildly reduced or preserved left ventricular ejection fraction of 40 per cent or greater.
Keren Haruvi, President Sandoz North America highlighted that denosumab is a medicine that can address primary and secondary bone loss, such as osteoporosis, as well as cancer-related skeletal events. Wyost Similarly, Wyost 120 mg/1.7 mL (70 mg/mL) injection is a human monoclonal antibody designed to bind to the RANKL protein.
Following this time period, the dosage is raised to one packet twice daily. Diarrhoea, nausea, upper respiratory tract infection and abdominal pain were reported to be the most common adverse events linked to Relyvrio. For the first three weeks, the recommended dose is one packet a day.
People over 65 make up only 14% of the population but account for 56% of hospitalizations for adverse drug events (ADEs) (Agency for Healthcare Research and Quality, AHRQ, 2021). Healthcare providers review medication lists, adjust dosages, and coordinate care among multiple specialists. References: Budnitz, D. Lovegrove, M.
These drugs have been rigorously tested by regulatory bodies around the world before they’re made available to ensure they work as labelled, but despite that, adverse events crop up. Looking at an individual’s genomic profile also provides an understanding of appropriate medication dosage. billion in the United States alone.
The event attracted over 200 attendees and continued the PULSE series’ role in providing a platform for industry learning. Bhatkar covered the requirements for sterile dosage manufacturing and the coordination between actuation and architectural design. The session began with a keynote address by Thiru M.
CPHI is a global platform that unites over 100,000 professionals from the pharmaceutical industry, hosting events in Spain, North America, the Middle East, India, Southeast Asia, Japan, and Korea. The team’s main goal at the event was to meet local medical companies in advance and explore their needs.
As with other JAKis, Rinvoq is accompanied by a boxed warning of increased risk of cardiovascular events (CVEs) and serious infections. However, based on general assessment, as expressed by interviewed KOLs, this advisory is not expected to significantly affect the adoption of this therapy in practices.
If approved, paliperidone palmitate extended-release injectable suspension (LY03010) is primed as a favourable option to treat schizophrenia, due to reduced dosage requirement of a once-a-month, yet it risks being hidden in a crowded long-acting injectable (LAI) market, GlobalData warns.
Adverse events (AEs) from the mAb were mild and included pain or redness at the infusion site, headache, abdominal pain, and hypertension, which resolved within a day. Partial protection was achieved at 1mg/kg, administered intravenously. Eight control participants who did not receive the mAb all developed malaria.
Session Highlights: The event began with a keynote address by Manish Kapoor, State Drugs Controller of Himachal Pradesh, who emphasised the critical role that water systems play in maintaining pharmaceutical product quality.
A benefit of this approach, according to Nadarajah, is that though the therapeutic can be used alongside traditional painkillers, the company’s real world studies show that patients using the digital therapeutic are able to reduce painkiller dosage and potentially stop them completely.
The decision was based on previously disclosed cardiac events that occurred in two participants who received MT-0169 at a 50mcg/kg dose One patient experienced asymptomatic grade 2 myocarditis, while the other had asymptomatic grade 3 cardiomyopathy & the dosage of MT-0169 was reduced by 90% to 5mcg/kg last year.
What are the indications and dosage for methylene blue? PMID 7073040 Moore TJ, Walsh CS, Cohen MR. Reported adverse event cases of methemoglobinemia associated with benzocaine products. Read More in the Series References Curry S. Methemoglobinemia. Ann Emerg Med. 1982;11(4):214-221. doi:10.1016/s0196-0644(82)80502-7. Arch Intern Med.
Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South Coast back in October, pharmaphorum had a chance to drop by the booth of EY and discuss not only its consulting operations, but the company’s Smart Reviewer, and their own assessment of the industry event itself.
JNJ-2113 was generally well tolerated by the treatment groups, with no evidence of a dose-dependent increase in specific adverse events. Results indicated the proportion of patients who achieved Psoriasis Area and Severity Index (PASI) 75 was 9.3 per cent for the placebo group, and 37.2 per cent, 58.1 per cent, 51.2 per cent, 65.1
In this video: Dr Suruchi Vishwasrao, Sr Scientist, Merck Life Sciences Topic: Patient-centric dosage forms: Oro dispersible films Key Highlights: [1] Distinct advantage of ORO includes patient centricity due to ease of administration. [2]
Part B of the LILAC study enrolled 132 participants with moderate-to-severe active CLE to receive one of three dosage levels of subcutaneous litifilimab (50, 150 or 450mg) or placebo. Litifilimab was generally well tolerated, with most reported adverse events (AEs) rated as mild or moderate. The most common AEs (reported in ?5
Last month, I had the privilege to attend a private event held by pharma-focused startup accelerator PharmStars where 11 startups organised around the theme of “Innovations in Neurological Disease” presented their work. So you can only imagine things can go wrong in that space.”. The future of neurological care.
The ADAPTA 50 capsule filler features innovative technical solutions to manage complex solid dosage forms such as product combination in hard gelatine capsules or powder micro-dosing for Dry Powder Inhalers. customers will have the opportunity to experience first hand various digital solutions aimed at reducing maintenance costs and downtime.
Counterfeit drugs, intentionally mislabeled or misrepresented, often contain substandard or harmful ingredients, incorrect dosages, or no active ingredients at all. Incidences of these fraudulent products have posed grave threats to individuals relying on medications for their well-being.
The safety profile of Kisqali at the 400mg dosage was also highlighted as well-tolerated, with most adverse events being of low grade. Additionally, Kisqali showed a consistent invasive disease-free survival (iDFS) benefit across various key subgroups.
This, in turn, led to a discussion on the role and importance of a surveillance system akin to the pharma industry to monitor and record adverse events associated with nutraceuticals. They also examined how technology can be leveraged and effectively deployed to provide specific dosages and ingredients as per patients’ varying needs.
While navigating changes has long been a challenge for the industry, the last two years’ events have made supply chain management significantly more difficult. Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception.
2] So, we need to cultivate and incentivise the right talent to build scientific acumen to accelerate progress in FR&D. [3] 3] We need robust strategies in place, including right technologies, effective policies, streamlined processes and clear regulatory pathways, to develop novel and complex formulations. [4]
In a study published in JAMA Internal Medicine , off-label use lacking strong scientific evidence had a higher adverse drug event rate compared with on-label use. However, off-label use with strong scientific evidence had the same risk for adverse drug events as on-label use. paediatric, pregnant, or psychiatric patients).
NOTE: The FDA recommends rosuvastatin dosage reductions in Asian patients to maximum 20 mg daily because pharmacokinetic studies have demonstrated an approximate two-fold increase in median exposure to rosuvastatin in Asian subjects when compared to Caucasian controls. Stopping Statins?
Adherence to prescribed medications is vital for controlling symptoms, preventing disease progression, and reducing the risk of adverse events such as heart attacks and strokes. Coordinating Dosage Timing: Aligning medication schedules with the patient’s daily routine can significantly improve adherence.
Adherence to prescribed medications is vital for controlling symptoms, preventing disease progression, and reducing the risk of adverse events such as heart attacks and strokes. Coordinating Dosage Timing: Aligning medication schedules with the patient’s daily routine can significantly improve adherence.
There have already been (with more coming) a slew of 40th anniversary celebration papers, analyses, and events in 2024, including: The Brookings Institution’s Hatch-Waxman at 40 The Association for Accessible Medicines’ Hatch-Waxman turns 40. And that name has stuck for many of us. Is it over the hill? (Or
Pharma companies can create apps that provide medical information, dosage calculators, appointment reminders, and other valuable features. Virtual Events and Webinars In a digital age, virtual events and webinars have gained prominence. This could include in-person events, conferences, print media, or direct mail.
The question now is how to tailor dosage even more closely to fit patients’ needs. “[L]ess Conjunctivitis is a known adverse event of IL-4/IL-13 inhibitors. The findings from the phase 3 trial of lebrikizumab noted that the most adverse side effects reported had been “nonserious and did not lead to treatment discontinuation”.
Dosing in Hypothyroidism The dosage of levothyroxine is individualized based on clinical response and serum thyroid stimulating hormone (TSH) and/or free T4 concentrations. There have been 177 adverse events reported related to brand switching. Individual T4 requirements correlate better with lean body weight than total body weight.
Originally granted approval in its largest market, the US, in 2017, Ozempic has subsequently obtained approval for three distinct dosages, 0.5mg, 1.0mg, and 2.0mg, for the treatment of type 2 diabetes.
Introduction Medication error is any preventable event that may harm patient. Medication Dosages Outpatient pharmacies are often high-pressure environments, with pharmacists feeling the need to rush medication preparation, but vigilance is key. When doing medication return, please be extra careful too. Gliclazide MR 120 mg BD.
Some drug products are susceptible to active pharmaceutical ingredient (API) shortages for a variety of reasons and bifurcation in the market for finished dosage form product between brand and generic drugs, for example, likewise can affect the degree of competition and product diversification in a market.
Panelists in this video: + Dr Sunil Tiwari, Sr VP R&D, Hetero Drugs + Dr Vaibhav Sihorkar, VP & Head- Developability & Formulations, Sai Life Sciences + Dr Sajeev Chandran, VP-R&D, Lupin + Dr Amarender Reddy Donthidi, VP & Head – R&D Injectables and Ophthalmics, Amneal Pharmaceuticals + Dr Abir Banerjee, VP-R&D (..)
As with other JAKis, Rinvoq is accompanied by a boxed warning of increased risk of cardiovascular events (CVEs) and serious infections. However, based on general assessment, as expressed by interviewed KOLs, this advisory is not expected to significantly affect the adoption of this therapy in practice.
Allison Siebecker, creator of the informative website SIBOinfo.com, the antibiotics metronidazole, rifaximin (Xifaxan ), and neomycin have been used to treat small intestinal bacterial overgrowth because of their ability to stay in the intestines, which prevents them from causing systemic adverse events. Instead, S. Boulardii per day.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content